The U.S. Department of Justice (DOJ) filed a complaint against a pharmaceutical company, claiming it had manipulated reimbursements for its eye care drug, thereby defrauding the country’s federal health insurance program and taxpayers of hundreds of millions of dollars.
Related Posts
Fugitive Alleged Cyber-fraud ‘Boss’ Charged With Money Laundering in Philippines
Huang Zhiyang was already facing human trafficking charges for allegedly running compounds where people were forced to carry… Read More
Turkey Secures Extradition of Mafia Suspects After Years on the Run
Armenia hands over two organized crime suspects Turkey wanted for years. Read More
Ex-Mozambique Finance Minister Sentenced in $2B ‘Tuna Bonds’ Fraud Scheme
Manuel Chang was sentenced to 102 months in prison for his part in stealing hundreds of millions of dollars in loans, which… Read More